Acetylcholine-regulated K+ current remodelling in the atrium after myocardial infarction and valsartan administration.

Qing-yan Zhao,Cong-xin Huang,Hong Jiang,Emmy Okello,Xi Wang,Yan-hong Tang,Geng-shan Li

DOI: https://doi.org/10.1016/S0828-282X(09)70069-8

2009-01-01

Abstract:AF is associated with increased I(K,ACh) after MI. Inhibition of increased IK,ACh may be the mechanism by which valsartan prevents AF following MI.

What problem does this paper attempt to address?

Effects of valsartan on ventricular arrhythmia induced by programmed electrical stimulation in rats with myocardial infarction

Kun-Li Jiao,Yi-Gang Li,Peng-Pai Zhang,Ren-Hua Chen,Yi Yu

DOI: https://doi.org/10.1111/j.1582-4934.2011.01502.x

Abstract:The impact of angiotensin II receptor blockers (ARBs) on electrical remodelling after myocardial infarction (MI) remains unclear. The purpose of the present study was to evaluate the effect of valsartan on incidence of ventricular arrhythmia induced by programmed electrical stimulation (PES) and potential link to changes of myocardial connexins (Cx) 43 expression and distribution in MI rats. Fifty-nine rats were randomly divided into three groups: Sham (n = 20), MI (n = 20) and MI + Val (20 mg/kg/day per gavage, n = 19). After eight weeks, the incidence of PES-induced ventricular tachycardia (VT) and fibrillation (VF) was compared among groups. mRNA and protein expressions of Cx43, angiotensin II type 1 receptor (AT1R) in the LV border zone (BZ) and non-infarct zone (NIZ) were determined by real-time PCR and Western blot, respectively. Connexins 43 protein and collagen distribution were examined by immunohistochemistry in BZ and NIZ sections from MI hearts. Valsartan effectively improved the cardiac function, reduced the prolonged QTc (163.7 ± 3.7 msec. versus 177.8 ± 4.5 msec., P < 0.05) after MI and the incidence of VT or VF evoked by PES (21.1% versus 55%, P < 0.05). Angiotensin II type 1 receptor expression was significantly increased in BZ and NIZ sections after MI, which was down-regulated by valsartan. The mRNA and protein expressions of Cx43 in BZ were significantly reduced after MI and up-regulated by valsartan. Increased collagen deposition and reduced Cx43 expression in BZ after MI could be partly attenuated by Valsartan. Valsartan reduced the incidence of PES-induced ventricular arrhythmia, this effect was possibly through modulating the myocardial AT1R and Cx43 expression.
Effects of valsartan on electrophysiology of guinea pig atrial myocytes

WANG Jiyun,HU Dayi

DOI: https://doi.org/10.3969/j.issn.1004-3594.2008.10.010

2008-01-01

Abstract:Objective To study the potential mechanism of angiotensin Ⅱ blocker(ARB)on atrial fibrillation from cellular electrophysiology of myocytes.Methods Whole-cell patch clamp technique was adopted.Current-clamp mode was used to record single cell action potential.The effect of ARB on action potential of guinea pig atrial myocytes were investigated.Patch-clamp mode was used to record delayed rectifier K+ currents(Ik).Results Valsartan 100 μM lengthened atrial myocyte action potential duration,especially APD50 from(52.2±6.5) ms to(58.6±7.8) ms(P<0.01)and APD90 from(94.0±11.7) ms to(105.3±14.0) ms(P<0.01),but had no effect on RMP and APA.Valsartan 100 μM reduced atrial myocytes peak Ik current from 5.33±0.13(pA/pF) to 4.49±0.48(pA/pF),voltage dependently.Conclusions At high concentration,valsartan increases APD of atrial myocytes of guinea pig without changing APA and RMP.Inhibiting Ik by valsartan is an important factor contributing to the prolongation of APD.By prolonging APD,valsartan may have potential in converting AF to sinus rhythm or in maintaining sinus rhythm after successful convertion.
Cross-talk Between Macrophages and Atrial Myocytes in Atrial Fibrillation

Zewei Sun,Dongchen Zhou,Xudong Xie,Shuai Wang,Zhen Wang,Wenting Zhao,Hongfei Xu,Liangrong Zheng

DOI: https://doi.org/10.1007/s00395-016-0584-z

IF: 12.416

2016-01-01

Basic Research in Cardiology

Abstract:Increased macrophage accumulation occurs in the atria of patients with atrial fibrillation (AF). However, the phenotype and functions of the macrophages in AF remain unclear. We investigated the macrophage-atrial myocyte interaction in AF patients and found that the increased macrophages were mainly pro-inflammatory macrophages (iNOS+, Arg1−). Tachypacing of HL-1 atrial myocytes also led to pro-inflammatory macrophage polarization. In addition, lipopolysaccharide (LPS)-stimulated pro-inflammatory macrophages-induced atrial electrical remodeling, evidenced by increased AF incidence and decreased atrial effective refractory period and L-type calcium currents (I Ca-L) in both canine and mouse AF models. Depletion of macrophages relieved LPS-induced atrial electrical remodeling, confirming the role of pro-inflammatory macrophages in the pathogenesis of AF. We also found that the effect of LPS-stimulated macrophages on atrial myocytes was mediated by secretion of interleukin 1 beta (IL-1β), which inhibited atrial myocyte quaking protein (QKI) expression. IL-1β knockout in macrophages restored the LPS-stimulated macrophage-induced inhibition of QKI and CACNA1C (α1C subunit of L-type calcium channel) in atrial myocytes. Meanwhile, QKI overexpression in atrial myocytes restored the LPS-stimulated macrophage-induced electrical remodeling through enhanced binding of QKI to CACNA1C mRNA, which upregulated the expression of CACNA1C as well as I Ca-L. In contrast, QKI knockout inhibited CACNA1C expression. Finally, using transcription factor activation profiling plate array and chromatin immunoprecipitation, we revealed that special AT-rich sequence binding protein 1 activated QKI transcription. Taken together, our study uncovered the functional interaction between macrophages and atrial myocytes in AF. AF induced pro-inflammatory macrophage polarization while pro-inflammatory macrophages exacerbated atrial electrical remodeling by secreting IL-1β, further inhibiting QKI expression in atrial myocytes, which contributed to I Ca-L downregulation. Our study demonstrates a novel molecular mechanism underlying the pathogenesis and progression of AF and suggests that QKI is a potential therapeutic target.
VIP Enhances Acetylcholine-Activated Potassium Current Via a Camp/pka Transduction Pathway

Jiangli Han,Yutao Xi,Geru Wu,Junping Sun,Shahrzad Abbasi,Jie Cheng

DOI: https://doi.org/10.1016/j.bpj.2012.11.3447

IF: 3.4

2013-01-01

Biophysical Journal

Abstract:Background: Recent studies have indicated that various components of cardiac nerve network may play important role in atrial fibrillation (AF). Vagal stimulation shortens atrial effective refractory period, predominantly via the activation of the acetylcholine-activated potassium channel (IKACh) that shortens action potential duration and increases the vulnerability to AF. Vasoactive intestine polypeptide (VIP), a neural polypeptide co-released with acetylcholine (ACh) largely from intrinsic cardiac neurons during vagal stimulation, was shown to contribute to the vulnerability to AF. However, the underlying mechanism remains unclear. The aim of this study is to investigate the effect of VIP on IKACh in the presence of ACh in rat atrial myocytes. Methods: The effects of VIP on IKACh in isolated adult rat atrial myocytes were investigated with voltage patch-clamp recording techniques. IKACh were recorded as an inwardly rectifying current activated by muscarinic agonist carbachol (CCH, 1μM). Furthermore, the post-synaptic signal pathway was investigated with Rp-cAMP (10 μM), a competitive antagonist of cyclic AMP (cAMP), H-89 (0.1μM), PKA inhibitor, and forskolin (0.1μM), an activator of adenylyl cyclase. Results: VIP (1μM) potentiates IKACh at a holding potential of −115 mV (VIP: −19.34 ± 5.22 pA/pF, n=12, vs. baseline: −15.85 ± 2.66 pA/pF, n=14, p<0.05). The enhancement of IKACh by VIP could be mitigated by Rp-cAMP (VIP plus Rp-cAMP: −8.24 ± 1.44 pA/pF n= 6; p<0.05 vs. baseline), and could be inhibited by H-89 (VIP plus H-89: −13.41 ± 2.95 pA/pF n=6; p=0.59 vs. baseline). Furthermore, these enhancements could be mimicked by an activator of adenylyl cyclase, forskolin (−27.35 ± 4.82pA/pF n= 5; p<0.01 vs. baseline). Conclusion: VIP enhanced IKACh in atrial myocytes which might contribute to vagal-induced APD shortening and is likely mediated by a cAMP-PKA dependent pathway.
Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation

Lu-Yi-Fei Li,Qi Lou,Guang-Zhong Liu,Jia-Chen Lv,Feng-Xiang Yun,Tian-Kai Li,Wen Yang,Hong-Yan Zhao,Li Zhang,Nan Bai,Cheng-Chuang Zhan,Jia Yu,Yan-Xiang Zang,Wei-Min Li,Lu-yi-fei Li,Guang-zhong Liu,Jia-chen Lv,Feng-xiang Yun,Tian-kai Li,Hong-yan Zhao,Cheng-chuang Zhan,Yan-xiang Zang,Wei-min Li

DOI: https://doi.org/10.1016/j.ejphar.2020.173120

IF: 5.195

2020-08-01

European Journal of Pharmacology

Abstract:Atrial structural and electrical remodelling play important roles in atrial fibrillation (AF). Sacubitril/valsartan attenuates cardiac remodelling in heart failure. However, the effect of sacubitril/valsartan on AF is unclear. The aim of this study was to evaluate the effect of sacubitril/valsartan on atrial electrical and structural remodelling in AF and investigate the underlying mechanism of action.Thirty-three rabbits were randomized into sham, RAP, and sac/val groups. HL-1 cells were subjected to control treatment or rapid pacing with or without LBQ657 and valsartan. Echocardiography, atrial electrophysiology, and histological examination were performed. The concentration of Ca2+ and expression levels of calcineurin, NFAT, p-NFAT, Cav1.2, collagen Ⅰ and Ⅲ, ANP, BNP, CNP, NT-proBNP, and ST2 in HL-1 cells, and IcaL in left atrial cells, were determined.We observed that compared to that in the sham group, the atrium and right ventricle were enlarged, myocardial fibrosis was markedly higher, AF inducibility was significantly elevated, and atrial effective refractory periods were shortened in the RAP group. These effects were significantly reversed by sacubitril/valsartan. Compared to that in the sham group, collagen Ⅰ and Ⅲ, NT-proBNP, ST2, calcineurin, and NFAT were significantly up-regulated, while p-NFAT and Cav1.2 were down-regulated in the RAP group, and sacubitril/valsartan inhibited these changes. Ca2+ concentration increased and ICaL density decreased in in vivo and in vitro AF models, reversed by sacubitril/valsartan.Sacubitril/valsartan attenuates atrial electrical remodelling and ameliorates structure remodelling in AF. This study paves the way for the possibility of clinical use of sacubitril/valsartan in AF patients.

pharmacology & pharmacy
Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation

Sarah Kettlewell,Francis L Burton,Godfrey L Smith,Antony J Workman

DOI: https://doi.org/10.1093/cvr/cvt087

2013-07-01

Abstract:Aims: Atrial fibrillation (AF) is increased in patients with heart failure resulting from myocardial infarction (MI). We aimed to determine the effects of chronic ventricular MI in rabbits on the susceptibility to AF, and underlying atrial electrophysiological and Ca(2+)-handling mechanisms. Methods and results: In Langendorff-perfused rabbit hearts, under β-adrenergic stimulation with isoproterenol (ISO; 1 µM), 8 weeks MI decreased AF threshold, indicating increased AF susceptibility. This was associated with increased atrial action potential duration (APD)-alternans at 90% repolarization, by 147%, and no significant change in the mean APD or atrial global conduction velocity (CV; n = 6-13 non-MI hearts, 5-12 MI). In atrial isolated myocytes, also under β-stimulation, L-type Ca(2+) current (I(CaL)) density and intracellular Ca(2+)-transient amplitude were decreased by MI, by 35 and 41%, respectively, and the frequency of spontaneous depolarizations (SDs) was substantially increased. MI increased atrial myocyte size and capacity, and markedly decreased transverse-tubule density. In non-MI hearts perfused with ISO, the I(CaL)-blocker nifedipine, at a concentration (0.02 µM) causing an equivalent I(CaL) reduction (35%) to that from the MI, did not affect AF susceptibility, and decreased APD. Conclusion: Chronic MI in rabbits remodels atrial structure, electrophysiology, and intracellular Ca(2+) handling. Increased susceptibility to AF by MI, under β-adrenergic stimulation, may result from associated production of atrial APD alternans and SDs, since steady-state APD and global CV were unchanged under these conditions, and may be unrelated to the associated reduction in whole-cell ICaL. Future studies may clarify potential contributions of local conduction changes, and cellular and subcellular mechanisms of alternans, to the increased AF susceptibility.
Sacubitril/Valsartan Can Reduce Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation.

Qiqi Wang,Chengui Zhuo,Qi Xia,Jiajia Jiang,Bifeng Wu,Dongchen Zhou,Zheyue Shu,Jianqiang Zhao,Miao Chen,Heng Chen,Zewei Sun,Biqi Zhang,Jie Han,Liangrong Zheng

DOI: https://doi.org/10.1007/s10557-022-07315-1

2022-01-01

Cardiovascular Drugs and Therapy

Abstract:SV can decrease AF recurrence after catheter ablation in patients with persistent AF at the 1-year follow-up. The mechanism for this process may be related to the reduction in the H2FPEF score in patients with preserved ejection fraction heart failure.
The Role of KACh Channels in Atrial Fibrillation

Vadim Mitrokhin,Nikola Hadzi-Petrushev,Viktor Kazanski,Stanislav Schileyko,Olga Kamkina,Anastasija Rodina,Alexandra Zolotareva,Valentin Zolotarev,Andre Kamkin,Mitko Mladenov

DOI: https://doi.org/10.3390/cells13121014

IF: 6

2024-06-11

Cells

Abstract:This manuscript explores the intricate role of acetylcholine-activated inward rectifier potassium (KACh) channels in the pathogenesis of atrial fibrillation (AF), a common cardiac arrhythmia. It delves into the molecular and cellular mechanisms that underpin AF, emphasizing the vital function of KACh channels in modulating the atrial action potential and facilitating arrhythmogenic conditions. This study underscores the dual nature of KACh activation and its genetic regulation, revealing that specific variations in potassium channel genes, such as Kir3.4 and K2P3.1, significantly influence the electrophysiological remodeling associated with AF. Furthermore, this manuscript identifies the crucial role of the KACh-mediated current, IKACh, in sustaining arrhythmia through facilitating shorter re-entry circuits and stabilizing the re-entrant circuits, particularly in response to vagal nerve stimulation. Experimental findings from animal models, which could not induce AF in the absence of muscarinic activation, highlight the dependency of AF induction on KACh channel activity. This is complemented by discussions on therapeutic interventions, where KACh channel blockers have shown promise in AF management. Additionally, this study discusses the broader implications of KACh channel behavior, including its ubiquitous presence across different cardiac regions and species, contributing to a comprehensive understanding of AF dynamics. The implications of these findings are profound, suggesting that targeting KACh channels might offer new therapeutic avenues for AF treatment, particularly in cases resistant to conventional approaches. By integrating genetic, cellular, and pharmacological perspectives, this manuscript offers a holistic view of the potential mechanisms and therapeutic targets in AF, making a significant contribution to the field of cardiac arrhythmia research.

cell biology
The Properties of the Transient Outward, Inward Rectifier and Acetylcholine-Sensitive Potassium Currents in Atrial Myocytes from Dogs in Sinus Rhythm and Experimentally Induced Atrial Fibrillation Dog Models

Zsófia Kohajda,Claudia Corici,Attila Kristóf,László Virág,Zoltán Husti,István Baczkó,László Sághy,András Varró,Norbert Jost

DOI: https://doi.org/10.3390/ph17091138

IF: 4.6

2024-09-01

Pharmaceuticals

Abstract:Aims: Atrial fibrillation (AF) is the most common chronic/recurrent arrhythmia, which significantly impairs quality of life and increases cardiovascular morbidity and mortality. Therefore, the aim of the present study was to investigate the properties of three repolarizing potassium currents which were shown to contribute to AF-induced electrical remodeling, i.e., the transient outward (Ito), inward rectifier (IK1) and acetylcholine-sensitive (IK,ACh) potassium currents in isolated atrial myocytes obtained from dogs either with sinus rhythm (SR) or following chronic atrial tachypacing (400/min)-induced AF. Methods: Atrial remodeling and AF were induced by chronic (4–6 weeks of) right atrial tachypacing (400/min) in dogs. Transmembrane ionic currents were measured by applying the whole-cell patch-clamp technique at 37 °C. Results: The Ito current was slightly downregulated in AF cells when compared with that recorded in SR cells. This downregulation was also associated with slowed inactivation kinetics. The IK1 current was found to be larger in AF cells; however, this upregulation was not statistically significant in the voltage range corresponding with atrial action potential (−80 mV to 0 mV). IK,ACh was activated by the cholinergic agonist carbachol (CCh; 2 μM). In SR, CCh activated a large current either in inward or outward directions. The selective IK,ACh inhibitor tertiapin (10 nM) blocked the outward CCh-induced current by 61%. In atrial cardiomyocytes isolated from dogs with AF, the presence of a constitutively active IK,ACh was observed, blocked by 59% with 10 nM tertiapin. However, in "AF atrial myocytes", CCh activated an additional, significant ligand-dependent and tertiapin-sensitive IK,ACh current. Conclusions: In our dog AF model, Ito unlike in humans was downregulated only in a slight manner. Due to its slow inactivation kinetics, it seems that Ito may play a more significant role in atrial repolarization than in ventricular working muscle myocytes. The presence of the constitutively active IK,ACh in atrial myocytes from AF dogs shows that electrical remodeling truly developed in this model. The IK,ACh current (both ligand-dependent and constitutively active) seems to play a significant role in canine atrial electrical remodeling and may be a promising atrial selective drug target for suppressing AF.

pharmacology & pharmacy,chemistry, medicinal
Effects of Valsartan on Ion Channel Currents of Guinea Pig Ventricular Myocytes

WANG Ji-yun,HU Da-yi,LIU Xiao-chao

DOI: https://doi.org/10.3969/j.issn.1673-6966.2006.04.005

2006-01-01

Abstract:Objective To study the effects of valsartan on ion channel currents of Guinea pig ventricular myocytes. Method Whole-cell patch clamp technique was adopted. Patch-clamp mode was used to record ion channel current, including L-type Ca~ 2+ current (L-I_ Ca ),Delayed rectifier K~+ currents (I_K),and inward rectifier K~+ currents (I_ K1 ). Results In ventricular myocytes valsartan 100 μM significantly inhibited the peak I_K current, from 7.15±0.78 ( pA/pF) to 6.42±0.85 ( pA/pF),voltage dependently. Valsartan 100 μM did not change the I_ K1 and L-I_ Ca currents. Conclusion Valsartan inhibits I_K and has no effects on I_ K1 and L-I_ Ca . Therefore, valsartan may lengthen APD by inhibiting I_K. The effects of valsartan on electrophysiology of guinea pig ventricular myocytes resemble that the of class Ⅲ antiarrhythmic medications.
Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation

Zenawit Girmatsion,Peter Biliczki,Angelika Bonauer,Gerhard Wimmer-Greinecker,Mirella Scherer,Anton Moritz,Alicia Bukowska,Andreas Goette,Stanley Nattel,Stefan H Hohnloser,Joachim R Ehrlich

DOI: https://doi.org/10.1016/j.hrthm.2009.08.035

IF: 6.779

Heart Rhythm

Abstract:Background: Atrial fibrillation (AF) is associated with increased inward-rectifier current activity that may stabilize atrial rotors maintaining the arrhythmia. Left atrial (LA) structures are important for AF maintenance, but previous studies have mostly evaluated changes in the right atrium. MicroRNA-1 (miR-1) reciprocally regulates inwardly rectifying potassium channel (Kir)2.1 expression in coronary disease, contributing to arrhythmogenesis. Objectives: This study sought to evaluate changes in miR-1 and Kir2 subunit expression in relation to I(K1) alterations in LA of patients with persistent AF. Methods: Atrial tissue was obtained from 62 patients (31 with AF) undergoing mitral valve repair or bypass grafting. Currents were recorded from isolated cells. Proteins were quantified from immunoblots. mRNA and miR-1 levels were measured with real-time polymerase chain reaction. Immunohistochemistry was applied to localize connexin (Cx) 43. Results: I(K1) density was increased in LA cells from patients with AF (at -100 mV: -5.9 +/- 1.3 vs. -2.7 +/- 0.7 sinus rhythm, P <.05). There was a corresponding increase in Kir2.1 protein expression, but no change in other Kir or Cx proteins. Expression of inhibitory miR-1 was reduced by approximately 86% in tissue samples of AF patients. Kir2.1 mRNA was significantly increased. No change in Cx43 localization occurred. Ex vivo tachystimulation of human atrial slices up-regulated Kir2.1 and down-regulated miR-1, suggesting a primary role of atrial rate in miR-1 down-regulation and I(K1) up-regulation. Conclusion: miR-1 levels are greatly reduced in human AF, possibly contributing to up-regulation of Kir2.1 subunits, leading to increased I(K1). Because up-regulation of inward-rectifier currents is important for AF maintenance, these results provide potential new insights into molecular mechanisms of AF with potential therapeutic implications.
Ca2+/Calmodulin-Dependent Protein Kinase II (CaMKII) Increases Small-Conductance Ca2+-Activated K+ Current in Patients with Chronic Atrial Fibrillation

Xuehui Fan,Yiyan Yu,Huan Lan,Xianhong Ou,Lijie Yang,Tao Li,Jiming Cao,Xiaorong Zeng,Miaoling Li

DOI: https://doi.org/10.12659/MSM.909684

2018-05-08

Abstract:BACKGROUND Increased small-conductance Ca2+-activated K+ current (SK), abnormal intracellular Ca2+ handling, and enhanced expression and activity of Ca2+/calmodulin-dependent protein kinase II (CaMKII) have been found in clinical and/or experimental models of atrial fibrillation (AF), but the cumulative effect of these phenomena and their mechanisms in AF are still unclear. This study aimed to test the hypothesis that CaMKII increases SK current in human chronic AF. MATERIAL AND METHODS Right atrial appendage tissues from patients with either sinus rhythm (SR) or AF and neonatal rat atrial myocytes were used. Patch clamp, qRT-PCR, and Western blotting techniques were used to perform the study. RESULTS Compared to SR, the apamin-sensitive SK current (IKAS) was significantly increased, but the mRNA and protein levels of SK1, SK2, and SK3 were significantly decreased. In AF, the steady-state Ca2+ response curve of [i]IKAS[/i] was shifted leftward and the [Ca2+]i level was significantly increased. CaMKII inhibitors (KN-93 or autocamtide-2-related inhibitory peptide (AIP)) reduced the IKAS in both AF and SR. The inhibitory effect of KN-93 or AIP on [i]IKAS[/i] was greater in AF than in SR. The expression levels of calmodulin, CaMKII, and autophosphorylated CaMKII at Thr287 (but not at Thr286) were significantly increased in AF. Furthermore, KN-93 inhibited the expression of (Thr287)p-CaMKII and SK2 in neonatal rat atrial myocytes. CONCLUSIONS SK current is increased via the enhanced activation of CaMKII in patients with AF. This finding may explain the difference between SK current and channels expression in AF, and thus may provide a therapeutic target for AF.
Influences of Angiotensin Ⅱ on Calcium Channel Current and Intracellular Free Calcium Concentration of Human Atrial Myocytes and the Antagonistic Effect of Amiodarone

张殿新,黄岚,王海昌,张荣庆,程何祥,刘兵,张清,郭文怡,李伟杰,秦涛

DOI: https://doi.org/10.3969/j.issn.0253-9934.2005.04.013

2005-01-01

Abstract:Objective To observe the influences of angiotensin Ⅱ (AngⅡ) on calcium channel current and intracellular free calcium concentration ([Ca 2+]i) of human atrial myocytes, so as to reveal the electrophysiological mechanisms of atrial arrhythmia induced by AngⅡ, and to investigate the antagonistic effect of amiodarone for providing the theoretical basis in treating atrial arrhythmias.Methods Single human atrial myocyte was isolated. The conventional whole-cell configuration of the patch-clamp technique was used to detect membrane I Ca-L, and confocal microscope was used with Fluo-3/AM as indicator to detect changes of [Ca 2+]i. The experiment comprised of four groups, ie, control group, AngⅡ group, amiodarone group and AngⅡ+amiodarone group.Results Comparing with the control group, AngⅡ of 0.1 μmol/L significantly increased the peak density of I Ca-L in human atrial myocyte [(-12.77±1.61) pA/pF vs (-5.78±0.81) pA/pF, P0.05). Amiodarone of 30 nmol/L had no significant effect on I Ca-L of human atrial myocyte [(-5.58±0.76) pA/pF], but it could antagonize the effects of AngⅡ. In AngⅡ+amiodarone group, the peak density of I Ca-L was [(-7.15±0.82)] pA/pF, which had a significant difference in comparing with the AngⅡ group (P0.05). The intracellular fluoresence intensity of single cardiomyocyte in both control and amiodarone groups was low. The intracellular fluoresence intensity of single cardiomyocyte in AngⅡ group was significantly higher than that in the control group after 15 minutes intervention (P0.05). When amiodarone was added simultaneously with AngⅡ intervention, the values were much lower comparing with AngⅡ group (P0.05).Conclusion AngⅡ of 0.1 μmol/L can significantly increase the peak density of I Ca-L and induce intracellular calcium overload in human atrial myocytes, which may participate in human atrial electrical remodeling and relevant to occurrence and progression of atrial fibrillation. Amiodarone can antagonize the above effects of AngⅡ in human atrial myocytes.
Irbesartan-Mediated At(1) Receptor Blockade Attenuates Hyposmotic-Induced Enhancement of I-Ks Current and Prevents Shortening of Action Potential Duration in Atrial Myocytes

Jie Wu,Wei-Guang Ding,Jin Zhao,Wei-Jin Zang,Hiroshi Matsuura,Minoru Horie

DOI: https://doi.org/10.1177/1470320312474855

2014-01-01

Journal of the Renin-Angiotensin-Aldosterone System

Abstract:Introduction: Stretch of the atrial membrane upregulates the slow component of delayed rectifier K + current ( I Ks ). Blockade of angiotensin II subtype 1 receptors (AT 1 R) attenuates this increase in I Ks . The present study aimed to examine the effects of irbesartan, a selective AT 1 R blocker (ABR), on both the enhancement of I Ks and the shortening of action potential duration (APD) induced by stretching atrial myocytes for exploring the mechanisms underlying the prevention of atrial fibrillation (AF) by ABR. Methods: Hyposmotic solution (Hypo-S) was used to stretch guinea pig atrial myocytes. I Ks and APD were recorded using the whole-cell patch-clamp technique. Results: Irbesartan (1–50 μM) attenuated the Hypo-S-induced increase in I Ks and shortening of APD 90 . Hypo-S increased the I Ks by 113.4%, whereas Hypo-S + 1 μM irbesartan and Hypo-S + 50 μM irbesartan increased the I Ks by only 74.5% and 70.3%, respectively. In addition, Hypo-S shortened the APD 90 by 19.0%, whereas Hypo-S + 1 μM irbesartan and Hypo-S + 50 μM irbesartan shortened the APD 90 by 12.1% and 12.0%, respectively. Conclusion: The actions of irbesartan on electrical changes induced by stretching atrial myocytes are associated with blocking AT 1 R. These actions may be beneficial for treating AF.
Electrophysiological Characteristics and Differential Densities of Intermediate Conductance Calcium-activated Potassium Channels in Rabbit Atrium and Thoracic Veins

Yazhe Ma,Jiangwen Liu,Youcheng Wang,Hongyi Zhao,Minghui Yang,Teng Wang,Xi Wang,Yanhong Tang,Qingyan Zhao,Congxin Huang

DOI: https://doi.org/10.22541/au.170668938.84821321/v1

2024-01-01

Abstract:Background: Intermediate-conductance calcium-activated potassium channels (KCa3.1) are important for automaticity of sinus nodes. Previous studies have identified that cardiomyocytes with pacemaker activities are existent in pulmonary vein (PV), superior vena cava (SVC). The aim of the present study was to explore the electrophysiological characteristics and differential densities of KCa3.1 in rabbit atrium. Methods: Immune-staining techniques and western blots were used to determine the KCa3.1 expression in PV, SVC, right atrium (RA), and left atrium (LA). Transmembrane action potentials (APs) of PVs, SVC, RA, and LA were recorded. Isoproterenol (1uM) and high calcium (5.4mM) were used to induce delayed afterdepolarization (DAD) and DAD-induced trigger activity. Results: The expression of KCa3.1 was significantly higher in the PVs and SVC than in the RA and LA. After super-fusion with isoproterenol (1μM) and high calcium (5.4mM), the delayed afterdepolarization (DAD) and DAD-induced triggered activity was induced in the PVs and SVC, but not in the RA and LA with isoproterenol and high calcium administration. TRAM-34 (5uM), a KCa3.1 inhibitor, inhibited DAD and DAD-induced triggered activity. Conclusions: Compared with atrium, thoracic veins are the most common sites genesis AF due to different distribution of KCa3.1. Blockade of KCa3.1 could eliminate DAD and DAD-induced trigger activity, KCa3.1 might be a promising target for foci AF.
In Silico Screening of the Key Electrical Remodelling Targets in Atrial Fibrillation-induced Sinoatrial Node Dysfunction

Jieyun Bai,Yaosheng Lu,Roshan Sharma,Jichao Zhao

DOI: https://doi.org/10.22489/cinc.2019.001

2019-12-30

Abstract:Atrial fibrillation (AF) is believed to shut down the normal function of sinoatrial node (SAN) by long-term overdrive suppression of its activity. Although AF-induced remodelling may impair SAN function, ionic mechanisms underlying sinus node dysfunction (SND) remain unclear. Here, this study investigated mechanisms by which AF-induced electrical remodelling promotes and perpetuates SND through biophysically detailed computer modelling. The recent Fabbri et al. model of human SAN cell and our mathematical model for human atrial cell action potential were modified to incorporate various experimental data on AF-induced changes in ionic channel currents and intracellular calcium handling. In our simulations, AF-induced electrical remodelling abbreviated atrial action potential duration (APD) and lowered heart rates. APD abbreviation can be mainly attributed to reduced ICaL and increased potassium currents (IKs and IK1). Down-regulation of If prolonged cycle length and thereby influenced the function of voltage clock in human SAN cells. Altogether, our simulated results indicate that voltage clock malfunction might be one mechanism underlying AF-induced SND and our SND mathematical model can be a useful in the design of experiments and the development of drugs.
Apamin-Sensitive K + Current Upregulation in Volume-Overload Heart Failure is Associated with the Decreased Interaction of CK2 with SK2

Dandan Yang,Tingzhong Wang,Yajuan Ni,Bingxue Song,Feifei Ning,Peijing Hu,Ling Luo,Ya Wang,Aiqun Ma

DOI: https://doi.org/10.1007/s00232-015-9839-0

2015-01-01

Abstract:Recent studies have shown that the sensitivity of apamin-sensitive K + current ( I KAS , mediated by apamin-sensitive small conductance calcium-activated potassium channels subunits) to intracellular Ca 2+ is increased in heart failure (HF), leading to I KAS upregulation, action potential duration shortening, early after depolarization, and recurrent spontaneous ventricular fibrillation. We hypothesized that casein kinase 2 (CK2) interacted with small conductance calcium-activated potassium channels (SK) is decreased in HF, and protein phosphatase 2A (PP2A) is increased on the opposite, upregulating the sensitivity of I KAS to intracellular Ca 2+ in HF. Rat model of volume-overload HF was established by an abdominal arteriovenous fistula procedure. The expression of SK channels, PP2A and CK2 was detected by Western blot analysis. Interaction and colocalization of CK2 with SK channel were detected by co-immunoprecipitation analysis and double immunofluorescence staining. In HF rat left ventricle, SK3 was increased by 100 % ( P < 0.05), and SK2 was not significantly changed. PP2A protein was increased by 94.7 % in HF rats ( P < 0.05), whereas the level of CK2 was almost unchanged. We found that CK2 colocalized with SK2 and SK3 in rat left ventricle. With anti-CK2α antibody, SK2 and SK3 were immunoprecipitated, the level of precipitated SK2 decreased by half, whereas precipitated SK3 was almost unchanged. In conclusion, the increased expression of total PP2A and decreased interaction of CK2 with SK2 may underlie enhanced sensitivity of I KAS to intracellular Ca 2+ in volume-overload HF rat.
Effects of Valsartan on the Action Potential of Guinea Pig Ventricular Myocytes

WANG Ji-yun,HU Da-yi,LIU Xiao-chao

DOI: https://doi.org/10.3969/j.issn.1673-6966.2006.02.007

2006-01-01

Abstract:Objective To study the potential mechanisms of angiotensin II blocker(ARB)on ventricular arrhythmias.Method Whole-cell patch clamp technique was adopted. Current-clamp mode was used to record single cell action potential. The effect of ARB on action potential of guinea pig ventricular myocytes were investigated. The parameters for analysis are resting membrane potential (RMP); action potential amplitude (APA); 50% action potential duration (APD) and 90% action potential duration. Results In ventricular myocytes, valsartan 5 mmol/L had no effect on RMP, APA, APD. Valsartan 100 mmol/L increased APD_ 50 from (334.2±14.4) ms to(375.2±12.0) ms( P 0.01)and APD_ 90 from ( 395.4±13.3 )ms to ( 451.4±9.5) ms( P 0.01). And still no effects were seen on RMP and APA. Conclusion At higher concentration, valsartan increase action potential duration of ventricular myocytes, especially APD_ 50 and APD_ 90 without any influence of APA and RMP. The effects of valsartan on electrophysiology of guinea pig ventricular myocytes resemble that of class Ⅲ antiarrhythmic medications. Whether valsartan has proarrhythmic side effect as class Ⅲ medications needs further study.
Simultaneous activation of the small conductance calcium-activated potassium current by acetylcholine and inhibition of sodium current by ajmaline cause J-wave syndrome in Langendorff-perfused rabbit ventricles

Yu-Dong Fei,Mu Chen,Shuai Guo,Akira Ueoka,Zhenhui Chen,Michael Rubart-von der Lohe,Thomas H Everett,Zhilin Qu,James N Weiss,Peng-Sheng Chen,Thomas H. Everett,James N. Weiss

DOI: https://doi.org/10.1016/j.hrthm.2020.07.036

IF: 6.779

2021-01-01

Heart Rhythm

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3>Concomitant apamin-sensitive small conductance, calcium activated potassium current (IKAS) activation and INa inhibition induce J-wave syndrome (JWS) in rabbit hearts. Sudden death in JWS occurs predominantly in men at night, when parasympathetic tone is strong.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3>To test the hypotheses that acetylcholine (ACh), the parasympathetic transmitter, activates IKAS and causes JWS in the presence of ajmaline.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3>We performed optical mapping in Langendorff-perfused rabbit hearts and whole-cell voltage clamp to determine IKAS in isolated ventricular cardiomyocytes.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3>ACh (1 μM) + ajmaline (2 μM) induced J-point elevations in all (6 male and 6 female) hearts from 0.01± 0.01 to 0.31 ± 0.05 mV (p<0.001), which were reduced by apamin (specific IKAS inhibitor, 100 nM) to 0.14 ± 0.02 mV (p<0.001). More J-point elevation was noted in males than females (p=0.037). Patch clamp studies showed that ACh significantly (p<0.001) activated IKAS in isolated male but not female ventricular myocytes (n=8). Optical mapping studies showed that ACh induced action potential duration (APD) heterogeneity, which was more significant in right than left ventricles. Apamin in the presence of ACh prolonged both APD25 (p<0.001) and APD80 (p<0.001), and attenuated APD heterogeneity. Ajmaline further increased APD heterogeneity induced by ACh. Ventricular arrhythmias were induced in 6/6 male and 1/6 female hearts (p= 0.015) in the presence of ACh and ajmaline, which was significantly suppressed by apamin in the former.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3>ACh activates ventricular IKAS. ACh and ajmaline induce J-wave syndrome and facilitate the induction of ventricular arrhythmias more in male than female ventricles.

cardiac & cardiovascular systems
Effects of the Late Sodium Current Inhibitor on the Interatrial Conduction Time and Acetylcholine-Induced Atrial Fibrillation

He Pengkang,Huo Yong,Zhou Jing,Wu Lin

DOI: https://doi.org/10.3760/cma.j.issn.1007-6638.2014.01.015

2014-01-01

Abstract:Objective To observe the frequency-and concentration-dependent effects of late sodium current inhibitor on the interatrial and intraventricular conduction time and acetylcholine-induced atrial fibrillation (AF).Methods New-Zealand White rabbit hearts were isolated and perfused in Langendorff mode.Hearts were paced at right atrium and para-His bundle area,and electrical signals were recorded from the left atrium and the apex to measure the interatrial and intraventricular conduction time.Results Ranolazine (1-15 μmol/L) prolonged interatrial conduction time in frequency-and concentration-dependent manners.Ranolazine prolonged the intraventricular conduction time at high concentration (＞15 μmol/L) but not at low and therapeutic concentrations (1-10 μmol/L).Ranolazine also exerted the ability of reducing AF burden and terminating AF induced by acetylcholine.In contrast,TTX(tetrodotoxin) and propafenone (1-3 μmol/L) prolonged both interatrial and intraventricular conduction time.Conclusion Ranolazine is relatively atrial selective to prolong interatrial conduction time in frequency-and concentration-dependent manners and can suppresses acetylcholine-induced AF.

Acetylcholine-regulated K+ current remodelling in the atrium after myocardial infarction and valsartan administration.

Effects of valsartan on ventricular arrhythmia induced by programmed electrical stimulation in rats with myocardial infarction

Effects of valsartan on electrophysiology of guinea pig atrial myocytes

Cross-talk Between Macrophages and Atrial Myocytes in Atrial Fibrillation

VIP Enhances Acetylcholine-Activated Potassium Current Via a Camp/pka Transduction Pathway

Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation

Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation

Sacubitril/Valsartan Can Reduce Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation.

The Role of KACh Channels in Atrial Fibrillation

The Properties of the Transient Outward, Inward Rectifier and Acetylcholine-Sensitive Potassium Currents in Atrial Myocytes from Dogs in Sinus Rhythm and Experimentally Induced Atrial Fibrillation Dog Models

Effects of Valsartan on Ion Channel Currents of Guinea Pig Ventricular Myocytes

Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation

Ca2+/Calmodulin-Dependent Protein Kinase II (CaMKII) Increases Small-Conductance Ca2+-Activated K+ Current in Patients with Chronic Atrial Fibrillation

Influences of Angiotensin Ⅱ on Calcium Channel Current and Intracellular Free Calcium Concentration of Human Atrial Myocytes and the Antagonistic Effect of Amiodarone

Irbesartan-Mediated At(1) Receptor Blockade Attenuates Hyposmotic-Induced Enhancement of I-Ks Current and Prevents Shortening of Action Potential Duration in Atrial Myocytes

Electrophysiological Characteristics and Differential Densities of Intermediate Conductance Calcium-activated Potassium Channels in Rabbit Atrium and Thoracic Veins

In Silico Screening of the Key Electrical Remodelling Targets in Atrial Fibrillation-induced Sinoatrial Node Dysfunction

Apamin-Sensitive K + Current Upregulation in Volume-Overload Heart Failure is Associated with the Decreased Interaction of CK2 with SK2

Effects of Valsartan on the Action Potential of Guinea Pig Ventricular Myocytes

Simultaneous activation of the small conductance calcium-activated potassium current by acetylcholine and inhibition of sodium current by ajmaline cause J-wave syndrome in Langendorff-perfused rabbit ventricles

Effects of the Late Sodium Current Inhibitor on the Interatrial Conduction Time and Acetylcholine-Induced Atrial Fibrillation